Skip to main content
. 2016 Apr 1;5(3):954–962. doi: 10.1039/c5tx00440c

Fig. 2. (A) The levels of serum ALT (U L–1) in the six groups shown as mean ± S.D. Compared with the control group, #P < 0.05, ##P < 0.01; compared with the INH&RFP group, *P < 0.05, **P < 0.01. (B) The levels of serum AST (U L–1) in the six groups shown as mean ± S.D. Compared with the control group, #P < 0.05, ##P < 0.01; compared with the INH&RFP group, *P < 0.05, **P < 0.01. (C) The levels of serum T.Bili (μmol L–1) in the six groups shown as mean ± S.D. Compared with the control group, #P < 0.05, ##P < 0.01; compared with the INH&RFP group, *P < 0.05, **P < 0.01.

Fig. 2